What are the recommended dosages for Attention Deficit Hyperactivity Disorder (ADHD) medications, including methylphenidate, Adderall (amphetamine and dextroamphetamine), and atomoxetine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosages for ADHD Medications

The recommended dosages for ADHD medications include starting methylphenidate at 5 mg twice daily for immediate-release and 10 mg once daily for extended-release (maximum 1.0 mg/kg/day), amphetamine/Adderall at 5-10 mg daily (maximum 50 mg daily), and atomoxetine at 1.2 mg/kg/day. 1

Methylphenidate Dosing

Immediate-Release Methylphenidate

  • Starting dose: 5 mg twice daily (before breakfast and lunch) 1
  • Effects typically last about 4 hours, requiring multiple daily doses 1, 2
  • Maximum daily dose: up to 1.0 mg/kg/day 1
  • Titration: Increase by 5-10 mg weekly increments based on symptom control 1

Extended-Release Methylphenidate

  • Starting dose: 10 mg once daily in the morning 1
  • Maximum daily dose: up to 1.0 mg/kg/day 1
  • Administration: Give in the morning to prevent sleep disturbances 1
  • Various formulations available (Concerta, Ritalin LA, etc.) with different durations of action (8-12 hours) 2

Amphetamine-Based Medications

Adderall (Mixed Amphetamine Salts)

  • Starting dose: 5-10 mg daily 1
  • Maximum daily dose: up to 50 mg daily 1
  • Titration: Adjust based on clinical response and side effects

Lisdexamfetamine (Vyvanse)

  • Starting dose: 20-30 mg once daily in the morning 3
  • Titration: Increase by 10 mg weekly 3
  • Maximum daily dose: 70 mg daily 3

Non-Stimulant Medications

Atomoxetine (Strattera)

  • Recommended dose: 1.2 mg/kg/day 1
  • Clinical studies showed efficacy at doses between 1.2-1.8 mg/kg/day 4
  • Can be administered as a single daily dose or split into two evenly divided doses 5
  • For children: Starting dose typically lower with gradual titration to target dose
  • Maximum recommended dose: 1.4-1.8 mg/kg/day or 100 mg daily (whichever is less) 4

Alpha-2 Adrenergic Agonists

  • Guanfacine and Clonidine can be used as monotherapy or adjunctive therapy with stimulants 1
  • These medications have minimal effects on appetite compared to stimulants 1

Dosing Considerations and Monitoring

Individualized Titration

  • Start at the lower end of the dosing range and titrate upward based on response
  • Assess target ADHD symptoms using standardized rating scales 1
  • Monitor for common side effects: sleep difficulties, reduced appetite, weight changes, headaches, stomach discomfort 1

Special Populations

  • For patients with tics: Methylphenidate, clonidine, guanfacine, and atomoxetine have been shown to reduce ADHD symptoms without necessarily worsening tics 6
  • For patients with comorbid anxiety: Atomoxetine may be particularly beneficial 4
  • For adults with ADHD: Similar dosing principles apply, though adult studies have used mean daily doses of approximately 35.8 mg of methylphenidate 7

Monitoring Requirements

  • Regular assessment of symptom control
  • Weight monitoring, especially with stimulants
  • Vital signs checks: annually in children and quarterly in adults 1
  • Follow-up within 2-4 weeks after dose adjustment 1

Important Considerations

  • Immediate-release methylphenidate effects typically last 4 hours, requiring multiple daily doses 2
  • Extended-release formulations help address adherence challenges during school hours 2
  • Atomoxetine has a negligible risk of abuse and is not a controlled substance, making it useful for patients at risk of substance abuse 5
  • Individual responses to medications vary significantly, necessitating careful dose titration 2
  • Plasma concentration monitoring is not clinically useful for methylphenidate dosing 2

Remember that medication should be part of a comprehensive treatment approach that may include behavioral interventions for optimal outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.